Company profile ALRN
After 39 days of this quarter the interest is at 30.0. Based on that we can calculate that during remaining 52 days it will total up to 70.0. Aileron Therapeutics expected interest is significantly lower compared to previous quarter (-61.7%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 155 | 72 -53.5% QoQ | 147 104.2% QoQ | 129 -12.2% QoQ |
| 2020 | 127 -18.1% YoY -1.6% QoQ | 224 211.1% YoY 76.4% QoQ | 210 42.9% YoY -6.2% QoQ | 306 137.2% YoY 45.7% QoQ |
| 2021 | 392 208.7% YoY 28.1% QoQ | 98 -56.2% YoY -75.0% QoQ | 142 -32.4% YoY 44.9% QoQ | 132 -56.9% YoY -7.0% QoQ |
| 2022 | 128 -67.3% YoY -3.0% QoQ | 96 -2.0% YoY -25.0% QoQ | 114 -19.7% YoY 18.8% QoQ | 55 -58.3% YoY -51.8% QoQ |
| 2023 | 102 -20.3% YoY 85.5% QoQ | 113 17.7% YoY 10.8% QoQ | 103 -9.6% YoY -8.8% QoQ | 183 232.7% YoY 77.7% QoQ |
| 2024 | 30 -70.6% YoY -83.6% QoQ | - | - | - |
The average 5 years interest of Aileron Therapeutics was 11.72 per week. The last year interest of Aileron Therapeutics compared to the last 5 years has changed by -12.88%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -6.5%.
Google Trends for ALRN-6924
Q4 +156.5% YoY, -1.9% QoQ | Q1 -54.1% YoY, -39.6% QoQ | Correlation: nan
After 39 days of this quarter the interest is at 41.0. Based on that we can calculate that during remaining 52 days it will total up to 96.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 162 inf% QoQ | 206 27.2% QoQ | 179 -13.1% QoQ |
| 2020 | 167 inf% YoY -6.7% QoQ | 94 -42.0% YoY -43.7% QoQ | 54 -73.8% YoY -42.6% QoQ | 169 -5.6% YoY 213.0% QoQ |
| 2021 | 67 -59.9% YoY -60.4% QoQ | 192 104.3% YoY 186.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 215 27.2% YoY inf% QoQ |
| 2022 | 22 -67.2% YoY -89.8% QoQ | 179 -6.8% YoY 713.6% QoQ | 115 inf% YoY -35.8% QoQ | 349 62.3% YoY 203.5% QoQ |
| 2023 | 114 418.2% YoY -67.3% QoQ | 115 -35.8% YoY 0.9% QoQ | 58 -49.6% YoY -49.6% QoQ | 131 -62.5% YoY 125.9% QoQ |
| 2024 | 41 -64.0% YoY -68.7% QoQ | - | - | - |
The average 5 years interest of ALRN-6924 was 10.07 per week. The last year interest of ALRN-6924 compared to the last 5 years has changed by -20.95%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -24.33%.
There is not enough data for Solid tumor treatments to provide analysis
There is not enough data for Solid tumor treatments to provide correlation calculation
There is not enough data for Solid tumor treatments to provide analysis
After 39 days of this quarter the interest is at 210.0. Based on that we can calculate that during remaining 52 days it will total up to 490.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 183 | 383 109.3% QoQ | 293 -23.5% QoQ | 339 15.7% QoQ |
| 2020 | 273 49.2% YoY -19.5% QoQ | 276 -27.9% YoY 1.1% QoQ | 313 6.8% YoY 13.4% QoQ | 298 -12.1% YoY -4.8% QoQ |
| 2021 | 303 11.0% YoY 1.7% QoQ | 285 3.3% YoY -5.9% QoQ | 310 -1.0% YoY 8.8% QoQ | 403 35.2% YoY 30.0% QoQ |
| 2022 | 526 73.6% YoY 30.5% QoQ | 323 13.3% YoY -38.6% QoQ | 276 -11.0% YoY -14.6% QoQ | 279 -30.8% YoY 1.1% QoQ |
| 2023 | 431 -18.1% YoY 54.5% QoQ | 305 -5.6% YoY -29.2% QoQ | 379 37.3% YoY 24.3% QoQ | 364 30.5% YoY -4.0% QoQ |
| 2024 | 210 -51.3% YoY -42.3% QoQ | - | - | - |
The average 5 years interest of Lymphoma treatments was 25.87 per week. The last year interest of Lymphoma treatments compared to the last 5 years has changed by 9.78%. The interest for Lymphoma treatments is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 13.24%.
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. AML treatments expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 14 | 40 185.7% QoQ | 40 0.0% QoQ | 57 42.5% QoQ |
| 2020 | 130 828.6% YoY 128.1% QoQ | 46 15.0% YoY -64.6% QoQ | 98 145.0% YoY 113.0% QoQ | 190 233.3% YoY 93.9% QoQ |
| 2021 | 48 -63.1% YoY -74.7% QoQ | 56 21.7% YoY 16.7% QoQ | 47 -52.0% YoY -16.1% QoQ | 64 -66.3% YoY 36.2% QoQ |
| 2022 | 97 102.1% YoY 51.6% QoQ | 97 73.2% YoY 0.0% QoQ | 90 91.5% YoY -7.2% QoQ | 72 12.5% YoY -20.0% QoQ |
| 2023 | 104 7.2% YoY 44.4% QoQ | 79 -18.6% YoY -24.0% QoQ | 96 6.7% YoY 21.5% QoQ | 43 -40.3% YoY -55.2% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of AML treatments was 5.78 per week. The last year interest of AML treatments compared to the last 5 years has changed by -3.46%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 38.12%.
There is not enough data for MDS treatments to provide analysis
There is not enough data for MDS treatments to provide correlation calculation
There is not enough data for MDS treatments to provide analysis
After 39 days of this quarter the interest is at 108.0. Based on that we can calculate that during remaining 52 days it will total up to 252.0. Small cell lung cancer treatments expected interest is significantly higher compared to previous quarter (+687.5%) and same quarter last year (+1160.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 19 | 20 5.3% QoQ | 25 25.0% QoQ | 15 -40.0% QoQ |
| 2020 | 21 10.5% YoY 40.0% QoQ | 11 -45.0% YoY -47.6% QoQ | 25 0.0% YoY 127.3% QoQ | 23 53.3% YoY -8.0% QoQ |
| 2021 | 19 -9.5% YoY -17.4% QoQ | 23 109.1% YoY 21.1% QoQ | 13 -48.0% YoY -43.5% QoQ | 8 -65.2% YoY -38.5% QoQ |
| 2022 | 5 -73.7% YoY -37.5% QoQ | 12 -47.8% YoY 140.0% QoQ | 34 161.5% YoY 183.3% QoQ | 24 200.0% YoY -29.4% QoQ |
| 2023 | 20 300.0% YoY -16.7% QoQ | 3 -75.0% YoY -85.0% QoQ | 34 0.0% YoY 1033.3% QoQ | 32 33.3% YoY -5.9% QoQ |
| 2024 | 108 440.0% YoY 237.5% QoQ | - | - | - |
The average 5 years interest of Small cell lung cancer treatments was 1.89 per week. The last year interest of Small cell lung cancer treatments compared to the last 5 years has changed by 86.24%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 113.33%.
There is not enough data for Aileron Therapeutics trials to provide analysis
There is not enough data for Aileron Therapeutics trials to provide correlation calculation
There is not enough data for Aileron Therapeutics trials to provide analysis
After 39 days of this quarter the interest is at 31.0. Based on that we can calculate that during remaining 52 days it will total up to 72.0. Renegade Therapeutics expected interest is significantly lower compared to previous quarter (-59.1%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 43 | 144 234.9% QoQ | 59 -59.0% QoQ | 16 -72.9% QoQ |
| 2020 | 32 -25.6% YoY 100.0% QoQ | 80 -44.4% YoY 150.0% QoQ | 75 27.1% YoY -6.2% QoQ | 21 31.2% YoY -72.0% QoQ |
| 2021 | 106 231.2% YoY 404.8% QoQ | 46 -42.5% YoY -56.6% QoQ | 16 -78.7% YoY -65.2% QoQ | 33 57.1% YoY 106.2% QoQ |
| 2022 | 31 -70.8% YoY -6.1% QoQ | 123 167.4% YoY 296.8% QoQ | 83 418.8% YoY -32.5% QoQ | 86 160.6% YoY 3.6% QoQ |
| 2023 | 62 100.0% YoY -27.9% QoQ | 153 24.4% YoY 146.8% QoQ | 213 156.6% YoY 39.2% QoQ | 176 104.7% YoY -17.4% QoQ |
| 2024 | 31 -50.0% YoY -82.4% QoQ | - | - | - |
The average 5 years interest of Renegade Therapeutics was 6.24 per week. The last year interest of Renegade Therapeutics compared to the last 5 years has changed by 83.01%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 102.12%.
There is not enough data for Aileron Therapeutics -stock -company to provide analysis
There is not enough data for Aileron Therapeutics -stock -company to provide correlation calculation
There is not enough data for Aileron Therapeutics -stock -company to provide analysis